Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects

A Phase II-III Trial Assessing the Efficacy and Safety of Three Doses of the ALK HDM Tablet in House Dust Mite Allergic Patients

The purpose of the trial is to determine if treatment of asthma patients allergic to house dust mites with the ALK HDM tablet can reduce the need of inhaled corticosteroids (ICS).

Inclusion Criteria:

• A history of house dust mite induced asthma
• Use of inhaled corticosteroids (ICS)
• Positive skin prick test to house dust mites
• Positive specific IgE to house dust mites

Exclusion Criteria:

• FEV1 lower than 70%